Resources search

Priority medicines for mothers and children 2011

WORLD HEALTH ORGANIZATION (WHO)
2011

Expand view

This resource presents a list of priority medicines for mothers and children to help countries and partners select and make available those medicines that will have the biggest impact on reducing maternal, newborn and child morbidity and mortality
WHO/EMP/MAR/2011.1

World health statistics 2010

WORLD HEALTH ORGANIZATION (WHO)
2010

Expand view

This annual compilation of health-related data for the World Health Organization's 193 member states, includes a summary of the progress made towards achieving the health-related Millennium Development Goals (MDGs) and associated targets

Action from the grassroots to parliament : access to essential medicines gets an airing in Zambia

CHOTA, Lazarus
et al
January 2010

Expand view

The unique position of stakeholders participating in the Medicines Transparency Alliance Zambia, means that the group are able to initiate discussions at many levels from grassroots to parliament. This is of great value in highlighting critical issues about the lack of access to essential medicines experienced by many citizens in Zambia and makes progress towards finding some solutions

The race against drug resistance : a report of the Center for Global Development’s drug resistance working group

NUGENT, Rachel
BLACK, Emma
BEITH, Alexandra
2010

Expand view

This report makes clear the need for urgent action to address the growing crisis of drug resistance. While there is no simple solution, there are achievable steps,that the health community, governments, donors, and the pharmaceutical industry can take to slow the spread of drug resistance. It says that retaining the medicines available now, developing new ones and other technology, and ensuring these resources continue to save lives in future generations must become a priority for global and national health organisations, both public and private

Taxing essential medicines : a sick tax that hinders access to treatment

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
December 2009

Expand view

This issue of the bulletin includes articles about the taxes on medicines and access to medicines; a report of a survey about medicine prices and availability in Latin America and the Caribbean; and about poor access to diabetes care in the Philippines

Survey of the quality of selected antimalarial medicines circulating in Madagascar, Senegal, and Uganda

UNITED STATES PHARMACOPEIA DRUG AND INFORMATION PROGRAM
November 2009

Expand view

This report focuses on three of 10 sub-Saharan countries that were covered by a study examining the quality of key antimalarial medicines. A total of 491 samples of anti-malarial medicines (both artemisinin-based combination therapy and sulfadoxine-pyrimethamine products) were collected from the public sector, the regulated private sector and the informal market in these three countries. The study revealed a high failure rate among sampled antimalarials in all three countries, based both on Minilab and full-compendial or quality control laboratory testing

Special issue on access to medicines, pricing and generics

September 2009

Expand view

This issue has articles about medicine prices in Vietnam, Thailand and South Africa, generic medicines in Malaysia and Australia, anti-retroviral therapy in South Africa, and legislation and regulation in the retail pharmacy sector in low-income countries.
Southern Med Review : Vol 2, Issue 2

Shifting allegiances in access to medicines : the Medicines Transparency Alliance in Ghana

CHETLEY, Andrew
DODOO, Alexander
OFORI-ADJEI, David
September 2009

Expand view

This article looks at the ideas that Medicines Transparency Alliance (MeTA) is testing, in order to achieve its long term goal to make high-quality essential medicines available and affordable to poor people who are currently unable to access them; and at how these ideas are being put into practice in Ghana. Ghana is one of the seven countries involved in the pilot phase of MeTA, the other countries are Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia

Safe medicines project - phase II : the Zambian case study

AFRICA FIGHTING MALARIA
March 2009

Expand view

This bulletin reports on the results of a study in which a range of antimalarial drugs were procured from private pharmacies, shops and kiosks within the urban and peri-urban areas of Lusaka, Zambia and tested to measure the active pharmaceutical ingredient content against internationally acceptable standards

WHO model list of essential medicines for children

WORLD HEALTH ORGANIZATION (WHO)
March 2009

Expand view

The medicines in this model list are intended for use for children up to the age of 12. There is a core list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost-effective treatment. There is also a complementary list of essential medicines for priority diseases, for which specialised diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are needed

Thailand's experience with compulsory licensing

MSF CAMPAIGN FOR ACCESS TO ESSENTIAL MEDICINES
2009

Expand view

In this recording Dr Suwit Wibulpolprasert of the Thai Ministry of Public Health talks about Thailand's experience when it issued compulsory licenses for two antiretroviral medicines in order to be able to treat more patients. Despite being put on a 'trade black list' by the US Government, the move was a success in public health terms, enabling the Thai Government to purchase more medicines and dramatically increase the availability of treatment for people living with AIDS

The Lancet : essential medicines out of reach of most people

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
December 2008

Expand view

The lead article of this edition of the WHO and HAI medicines pricing survey quarterly bulletin picks up on an article published in the Lancet which highlights the financial burden faced by many people living in low and middle income countries when having to pay for essential medicines

UN MDG gap task force report

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
September 2008

Expand view

Making essential medicines more affordable and more widely available are essential in helping to meet the millennium development goals. The lead article of this edition of HAI and WHO's medicines pricing survey bulletin, looks at UN Secretary General Ban Ki Moon's response to a mid-term progress report from the MDG Gap Task Force

Seizing the opportunity on AIDS and health systems

OOMMAN, Nandini
BERNSTEIN, Michael
ROSENZWEIG, Steven
August 2008

Expand view

This is a comparison of donor interactions with national health systems in Mozambique, Uganda, and Zambia - specifically: the health information systems, the supply chain systems for essential medicines, and human resources for health. It focuses on the US President’s Emergency Plan for AIDS Relief, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank’s Africa Multi-Country AIDS Program

Antimalarial drug quality in the most severely malarious parts of Africa - a six country study

BATE, Roger
et al
May 2008

Expand view

This article describes research conducted on a range of antimalarial drugs, procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries which were subjected to semi-quantitative thin-layer chromatography (TLC) and dissolution testing to measure active pharmaceutical ingredient content against internationally acceptable standards

Guidelines on policies that affect medicine prices

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION(WHO)
2008

Expand view

At a time when over 50 medicines pricing surveys had been completed around the world using the HAI/WHO methodology, the lead article to this edition of the medicines pricing survey bulletin considers the need for guidelines to assist in the creation of policy changes that will help to reduce the price of essential medicines

Pages

E-bulletin

Source e-bulletin on Disability and Inclusion

Subscribe to updates